Pygo2 activates MDR1 expression and mediates chemoresistance in breast cancer via the Wnt/β-catenin pathway. (Record no. 25732352)
[ view plain ]
000 -LEADER | |
---|---|
fixed length control field | 01514 a2200445 4500 |
005 - DATE AND TIME OF LATEST TRANSACTION | |
control field | 20250517081132.0 |
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
fixed length control field | 201708s 0 0 eng d |
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER | |
International Standard Serial Number | 1476-5594 |
024 7# - OTHER STANDARD IDENTIFIER | |
Standard number or code | 10.1038/onc.2016.10 |
Source of number or code | doi |
040 ## - CATALOGING SOURCE | |
Original cataloging agency | NLM |
Language of cataloging | eng |
Transcribing agency | NLM |
100 1# - MAIN ENTRY--PERSONAL NAME | |
Personal name | Zhang, Z-M |
264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE | |
Date of production, publication, distribution, manufacture, or copyright notice | 20170831 |
245 00 - TITLE STATEMENT | |
Title | Pygo2 activates MDR1 expression and mediates chemoresistance in breast cancer via the Wnt/β-catenin pathway. |
Medium | [electronic resource] |
260 ## - PUBLICATION, DISTRIBUTION, ETC. | |
Name of publisher, distributor, etc. | Oncogene |
Date of publication, distribution, etc. | 09 2016 |
300 ## - PHYSICAL DESCRIPTION | |
Extent | 4787-97 p. |
Other physical details | digital |
500 ## - GENERAL NOTE | |
General note | Publication Type: Journal Article |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | ATP Binding Cassette Transporter, Subfamily B |
General subdivision | genetics |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Animals |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Breast Neoplasms |
General subdivision | drug therapy |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Doxorubicin |
General subdivision | administration & dosage |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Drug Resistance, Neoplasm |
General subdivision | genetics |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Female |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Gene Expression Regulation, Neoplastic |
General subdivision | drug effects |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Humans |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Intracellular Signaling Peptides and Proteins |
General subdivision | genetics |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | MCF-7 Cells |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Mice |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Neoplastic Stem Cells |
General subdivision | metabolism |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Transcriptional Activation |
General subdivision | drug effects |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Xenograft Model Antitumor Assays |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Wu, J-F |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Luo, Q-C |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Liu, Q-F |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Wu, Q-W |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Ye, G-D |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | She, H-Q |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Li, B-A |
773 0# - HOST ITEM ENTRY | |
Title | Oncogene |
Related parts | vol. 35 |
-- | no. 36 |
-- | p. 4787-97 |
856 40 - ELECTRONIC LOCATION AND ACCESS | |
Uniform Resource Identifier | <a href="https://doi.org/10.1038/onc.2016.10">https://doi.org/10.1038/onc.2016.10</a> |
Public note | Available from publisher's website |
No items available.